from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3155/nuoK

LFCtreatmentdescriptionclass of inhibitor

-1.745

Amikacinug/mL Amikacintranslation

-2.570

Cap5-10ug/mL Capreomycintranslation

-2.360

Rox10-50 ug/mL Roxithromycintranslation

-1.724

SM2-5 ug/mL Streptomycintranslation

-4.201

Tet5-10 ug/mL Tetracyclinetranslation

-0.828

Rif0.2-5ug/mL Rifampicintranscription

-0.118

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.272

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.166

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.386

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.327

Clofazimine10-13 ug/mL Clofaziminerespiration

0.906

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.298

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.308

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.820

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.270

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.112

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.769

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.362

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.350

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.502

KCN5-20 ug/mL Potassium cyaniderespiration

0.199

NaN30.2-2 mM Sodium aziderespiration

-0.000

Nigericin50 uM Nigericinrespiration

-0.973

TRC10-150 ug/mL Triclosanrespiration

1.005

TRZ10-25 ug/mL Thioridazinerespiration

-0.147

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.907

menadione6-10 ug/mL Menadionerespiration

-1.231

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.769

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.680

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.019

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.130

NRP_1Non-replicating persistence stage 1dosRassociated

0.759

Amp0.2mg/mL AmpicillincellWall

0.531

Cephalexin20-100 ug/mL CephalexincellWall

0.286

Cerulenin0.32-5 ug/mL CerulenincellWall

0.887

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.258

EMB10-20 ug/mL EthambutolcellWall

0.178

Eta12-40 ug/mL EthionamidecellWall

0.528

INH0.2-0.4 ug/mL IsoniazidcellWall

0.134

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.093

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.286

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.219

BZA0.12 mg/mL BenzamidearomaticAmides

0.405

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.431

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.507

H2O24 mM hydrogen peroxideDNAdamaging

-0.102

Levo10 ug/mL LevofloxacinDNAdamaging

0.373

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.080

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.603

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.133

UVUV-irradiationDNAdamaging

-0.595

ARP41-4 ug/mL Antitubercular compound ARP4?

0.516

Antimycin12.5-50 ug/mL Antimycin A?

-0.006

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.555

PA_110-50 ug/mL Antitubercular compound PA-1?

1.022

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.150

PA8240.2-2 ug/mL PA-824?

-0.582

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.451

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.434

Verapamil50 uM Verapamil?

0.241

mercaptoethanol2 mM 2-Mercaptoethanol?

0.730

methoxatin10-20 ug/mL Methoxatin?